Wednesday, July 8, 2026

pharma · Acute Pain · Pharmacokinetics · ENSC

Ensysce Biosciences

Ensysce Biosciences clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

La Jolla, USA HQ
2008 Founded
13 Employees
Public company Type
ENSC · NYSE Ticker
Company details
Status
Public
HQ
La Jolla, USA
Founded
2008
Employees
13
Programs
6
Drugs
2
Patents
2
Intelligence · Clinical Programs

Ensysce Biosciences projects

4 ClinicalTrials.gov programs sponsored by Ensysce Biosciences.

Ensysce Biosciences has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. PF614

    Ensysce Biosciences

    Healthy

    phase 1 small molecule completed

    1 trial
  2. PF614

    Ensysce Biosciences

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. PF614

    Ensysce Biosciences

    Recreational Drug Use

    phase 1 small molecule completed

    2 trials
  4. PF614 capsule

    Ensysce Biosciences

    Pharmacokinetics

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Ensysce Biosciences have?

4 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.